Please login to the form below

Not currently logged in
Email:
Password:

Amarillo Biosciences appoints Stephen Chen chair and CEO

He replaces Joseph Cummins, who will remain as the US biotech's chief operating officer

Amarillo Biosciences has selected Dr Stephen Chen, one of its directors, to take on the roles of CEO and chair.

Dr Chen takes over from Joseph Cummins, who will remain as the US biotech's president and chief operating officer.

Chen has been at Texas-based Amarillo since 1996, and has over 30 years' experience in the pharma and healthcare industry.

During this time he has held executive positions in R&D and business at several major pharma companies, including Burroughs Wellcome (now GlaxoSmithKline), Miles Pharmaceuticals (now Bayer), ICI America (now AstraZeneca), and Ciba-Geigy (now Novartis).

Since May 1992, he has been CEO of STC International, a US-based healthcare investment firm.

As CEO at Amarillo, Chen will lead operations at the company, which focus on research into the use of low-dose, oral interferon as a treatment for a variety of conditions, including influenza, hepatitis C, chronic cough and HIV-related infections.

27th February 2012

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
11 London

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...

Latest intelligence

dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...
Data security
Concerns about data security are building a strong case for clinical mobility in EMEA
Electronic medical records have transformed the storage of sensitive information but how can the healthcare sector continue to protect patient and staff data?...
Mainimage2
The role of digital health technology tools in supporting medical adherence
How DHT-based digital interventions can help to support patients and improve adherence...